Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 4 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 7 hours agoPfizer (PFE -0.14%) investors have been through a lot of ups and downs over the past few years....
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 5 hours agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 20 hours agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 5 hours agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 11 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena via Yahoo Finance· 1 day agoTakeda and Pfizer have announced a positive Phase III HD21 trial, evaluating ADCETRIS (brentuximab...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 4 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 3 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...